Abstract:Journal of Endovascular Therapy, Ahead of Print. Background:Secondary aortic intervention (SAI) following thoracic endovascular aortic repair (TEVAR) is not uncommon. However, a satisfactory management system has not been established for these patients. We aimed to report our single-center experience with SAI after prior TEVAR for type B aortic dissection (TBAD).Methods:From January 2010 to May 2017, 860 eligible patients with TBAD underwent TEVAR. One hundred seven (12.4%) patients required SAI, either endovascularly (n=76) or surgically (n=31). The main indications for SAI were entry flow (n=58 [54.2%]), aneurysm expansion of the proximal or remote aorta (n=26 [24.3%]), retrograde type A aortic dissection (n=11 [10.3%]), distal stent-graft–induced new entry tear (n=6 [5.6%]), and stent migration (n=4 [3.7%]). The Kaplan-Meier curves were generated to determine the degree of freedom from SAI and the prognosis. Cox proportional hazards were used to screen for risk factors for SAI and poor prognosis.Results:The overall 30-day mortality rate after SAI was 4.7% (n=5): endovascular (n=2 [2.6%]) vs open surgery (n=3 [9.7%]; p=0.145). The cumulative survival rates with or without SAI were 86.3%±3.6% vs 95.7%±0.8% at 3 years and 82.0%±4.2% vs 92.2%±1.1% at 5 years, respectively (log-rank p<0.001). Although no significant difference in survival was observed, the incidence of SAI was significantly greater in patients who underwent TEVAR during the chronic phase (acute [11.6%] vs subacute [9.6%] vs chronic [27.8]; p<0.001). Multivariate regression analysis revealed that prior TEVAR in the chronic phase (hazard ratio [HR]=1.73, 95% confidence interval [CI]=1.03-2.90; p=0.039), maximum aortic diameter (HR=1.05, 95% CI=1.04-1.07; p<0.001), and arch involvement (HR=1.48, 95% CI=1.01-2.18; p=0.048) were predictors of the incidence of SAI. In addition, the maximum aortic diameter was demonstrated to be the only risk factor for prognosis after adjusting for confounding factors.Conclusions:Thoracic endovascular aortic repair for chronic TBAD patients should be reconsidered. Open surgery is preferable for those with proximal progression, whereas endovascular treatment is more suitable for distal lesions. Close surveillance and timely reintervention after TEVAR, whether via endovascular techniques or open surgery, are necessary to prevent devastating complications.Clinical ImpactThe management of patients with type B aortic dissection (TBAD) after thoracic endovascular aortic repair (TEVAR) is challenging. We summarized our single-center experience regarding secondary aortic intervention after TEVAR for TBAD. We found that TEVAR for chronic TBAD patients should be carefully evaulated, and open surgery is recommended for those with proximal progession, while endovascular treatment is more preferable for distal lesions.

Aortic-Related Readmission after Thoracic Endovascular Aortic Repair for Type B Aortic Dissection Patients: A Single-Center Retrospective Study.

Long-Term Aortic Remodeling after Thoracic Endovascular Aortic Repair of Acute, Subacute, and Chronic Type B Dissections.

Reintervention after Thoracic Endovascular Aortic Repair of Uncomplicated Type B Aortic Dissection

Ten-Year Clinical Characteristics and Early Outcomes of Type B Aortic Dissection Patients with Thoracic Endovascular Aortic Repair.

Retrograde type A aortic dissection during or after thoracic endovascular aortic repair: a single center 16-year experience

Incidence, Predictors, and Implications of Secondary Aortic Intervention Following Thoracic Endovascular Aortic Repair for Type B Dissection

Midterm Prognosis of Type B Aortic Dissection with and Without Dissecting Aneurysm of Descending Thoracic Aorta after Endovascular Repair

Long-term Results of Thoracic Endovascular Aortic Repair for Type B Aortic Dissection and Risk Factors for Survival

Application of Antithrombotic Drugs in Patients with Acute Type B Aortic Dissection Underwent Thoracic Endovascular Aortic Repair

Surgical Repair of Two Kinds of Type A Aortic Dissection After Thoracic Endovascular Aortic Repair

Safety and Efficacy of Thoracic Endovascular Aortic Repair for Acute Stanford Type B Aortic Dissection with Retrograde Type A Intramural Hematoma.

Long-term results of etiology-based thoracic endovascular aortic repair: a single-center experience

Predicting adverse events after thoracic endovascular aortic repair for patients with type B aortic dissection

[Surgical treatment of Stanford type A aortic dissection after thoracic endovascular aortic repair]

Outcomes and Aortic Remodelling after Proximal Thoracic Endovascular Aortic Repair of Post Type B Aortic Dissection Thoracic Aneurysm

The Mid-to Long-Term Complications of Endovascular Repair for Stanford Type B Aortic Dissection

Long‐Term Outcomes of Chronic Type B Aortic Dissection Treated by Thoracic Endovascular Aortic Repair

Long-term Outcomes of Thoracic Endovascular Aortic Repair for Chronic Stanford Type B Aortic Dissection

Mid-term Outcomes from a Multicenter Study: is TEVAR Safe for Ascending Aortic Dissection?

Thoracic Endovascular Aortic Repair for Traumatic Type B Aortic Dissection: a 5-Year Experience from a Single Center

Retrograde Type A Aortic Dissection after Thoracic Endovascular Aortic Repair: Incidence, Time Trends and Risk Factors